Stakeholders want Makary’s voucher program paused, call for FDA independence
BioSpace
The FDA hasn't been transparent and open enough with how it has implemented the Commissioner's National Priority Voucher program, patient, industry and trade groups said Thursday.
pharminent
June 5, 2026 (Last updated: June 5, 2026)
BioSpace
The FDA hasn’t been transparent and open enough with how it has implemented the Commissioner’s National Priority Voucher program, patient, industry and trade groups said Thursday.
